Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: My theory on share buybacks

SCHEDULE 14A INFORMATION


Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Date:  September 17, 2007

STATEMENT:  We’ve suspended share repurchases for a while because I no longer believe this is the best use of the company’s cash at this time. Although we still believe our shares are undervalued, I strongly believe we can put that money to better and more profitable use elsewhere.

Date:  Patriot Scientific Provides Details of Share Buyback
Thursday September 27, 4:05 pm ET

They had to announce because in the 14a they said they had suspended the share repurchase.

Share
New Message
Please login to post a reply